Ma J, Qu W, Scarborough P E, Tomer K B, Moomaw C R, Maronpot R, Davis L S, Breyer M D, Zeldin D C
Laboratories of Pulmonary Pathobiology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 1999 Jun 18;274(25):17777-88. doi: 10.1074/jbc.274.25.17777.
A cDNA encoding a new cytochrome P450 was isolated from a mouse liver library. Sequence analysis reveals that this 1,886-base pair cDNA encodes a 501-amino acid polypeptide that is 69-74% identical to CYP2J subfamily P450s and is designated CYP2J5. Recombinant CYP2J5 was co-expressed with NADPH-cytochrome P450 oxidoreductase in Sf9 cells using a baculovirus system. Microsomal fractions of CYP2J5/NADPH-cytochrome P450 oxidoreductase-transfected cells metabolize arachidonic acid to 14,15-, 11,12-, and 8, 9-epoxyeicosatrienoic acids and 11- and 15-hydroxyeicosatetraenoic acids (catalytic turnover, 4.5 nmol of product/nmol of cytochrome P450/min at 37 degrees C); thus CYP2J5 is enzymologically distinct. Northern analysis reveals that CYP2J5 transcripts are most abundant in mouse kidney and present at lower levels in liver. Immunoblotting using a polyclonal antibody against a CYP2J5-specific peptide detects a protein with the same electrophoretic mobility as recombinant CYP2J5 most abundantly in mouse kidney microsomes. CYP2J5 is regulated during development in a tissue-specific fashion. In the kidney, CYP2J5 is present before birth and reaches maximal levels at 2-4 weeks of age. In the liver, CYP2J5 is absent prenatally and during the early postnatal period, first appears at 1 week, and then remains relatively constant. Immunohistochemical staining of kidney sections with anti-human CYP2J2 IgG reveals that CYP2J protein(s) are present primarily in the proximal tubules and collecting ducts, sites where the epoxyeicosatrienoic acids are known to modulate fluid/electrolyte transport and mediate hormonal action. In situ hybridization confirms abundant CYP2J5 mRNA within tubules of the renal cortex and outer medulla. Epoxyeicosatrienoic acids are endogenous constituents of mouse kidney thus providing direct evidence for the in vivo metabolism of arachidonic acid by the mouse renal epoxygenase(s). Based on these data, we conclude that CYP2J5 is an enzymologically distinct, developmentally regulated, protein that is localized to specific nephron segments and contributes to the oxidation of endogenous renal arachidonic acid pools. In light of the well documented effects of epoxyeicosatrienoic acids in modulating renal tubular transport processes, we postulate that CYP2J5 products play important functional roles in the kidney.
从一个小鼠肝脏文库中分离出一个编码新细胞色素P450的cDNA。序列分析表明,这个1886个碱基对的cDNA编码一个501个氨基酸的多肽,它与CYP2J亚家族细胞色素P450的同源性为69 - 74%,被命名为CYP2J5。使用杆状病毒系统,重组CYP2J5与NADPH - 细胞色素P450氧化还原酶在Sf9细胞中共表达。CYP2J5 / NADPH - 细胞色素P450氧化还原酶转染细胞的微粒体部分将花生四烯酸代谢为14,15 -、11,12 - 和8,9 - 环氧二十碳三烯酸以及11 - 和15 - 羟基二十碳四烯酸(催化周转率,在37℃时为4.5 nmol产物/nmol细胞色素P450/分钟);因此CYP2J5在酶学上是独特的。Northern分析表明,CYP2J5转录本在小鼠肾脏中最丰富,在肝脏中的水平较低。使用针对CYP2J5特异性肽的多克隆抗体进行免疫印迹检测到一种与重组CYP2J5具有相同电泳迁移率的蛋白质,在小鼠肾脏微粒体中含量最丰富。CYP2J5在发育过程中以组织特异性方式受到调节。在肾脏中,CYP2J5在出生前就存在,并在2 - 4周龄时达到最高水平。在肝脏中,CYP2J5在产前和产后早期不存在,在1周时首次出现,然后保持相对稳定。用抗人CYP2J2 IgG对肾脏切片进行免疫组织化学染色显示,CYP2J蛋白主要存在于近端小管和集合管中,已知环氧二十碳三烯酸在这些部位调节液体/电解质转运并介导激素作用。原位杂交证实肾皮质和外髓的小管内有丰富的CYP2J5 mRNA。环氧二十碳三烯酸是小鼠肾脏的内源性成分,因此为小鼠肾脏环氧合酶对花生四烯酸的体内代谢提供了直接证据。基于这些数据,我们得出结论,CYP2J5是一种在酶学上独特、受发育调节的蛋白质,定位于特定的肾单位节段,并有助于内源性肾脏花生四烯酸池的氧化。鉴于环氧二十碳三烯酸在调节肾小管转运过程中的作用已得到充分记录,我们推测CYP2J5的产物在肾脏中发挥重要的功能作用。